Gilead Sciences (GILD) has prevailed in a long-running legal battle after the California Supreme Court ruled in the company’s favour over its tenofovir-based HIV treatments. The decision brings years of complex litigation
Team England’s Commonwealth Games gold medal-winning men’s 3×3 basketball team is set to return to Paternoster Square in central London on Thursday 6 August. The players, Jamell Anderson, Ashley Hamilton, Dwayne Lautier-Ogunleye
More
The Section 232 pharmaceutical tariff regime is no longer a looming threat for the industry — it is now active law following the July 31, 2026, deadline. President Trump’s April 2, 2026,
More
In March 2026, a coalition of trade groups filed a federal lawsuit challenging California’s SB 343, widely known as the Truth in Recycling Act. Plaintiffs argue the law unconstitutionally restricts truthful commercial
More
Blanche has issued a memo claiming to rescind the Trump ally slush fund, a move that could be enough to advance his nomination out of committee. The memo is not in the
More
Palantir Technologies (PLTR) has emerged as one of the most closely watched stocks in the market, with investors tracking its AI-driven growth trajectory with considerable interest. The company has built a reputation
More
Reform UK deputy leader Richard Tice is under investigation by the parliamentary standards watchdog for allegedly failing to declare an interest during a parliamentary debate. Daniel Greenberg, the parliamentary standards commissioner, confirmed
More
A potential merger between AstraZeneca and Bristol Myers Squibb has been circulating on Wall Street, and the numbers involved are staggering. The Financial Times reported that the two pharmaceutical giants have held
More
Courts across the United States are being buried under a growing tide of AI-generated filings, deepfake evidence, and hallucinated legal pleadings with no end in sight. Since April 2023, Damien Charlotin, a
More
London stocks are set to open higher on the first trading day of August, buoyed by falling oil prices and major corporate news. FTSE 100 futures point to a gain of 25
More
Halfords Group (HFD) is set to return to the FTSE 250 index, replacing Bluefield Solar Income Fund in the latest reshuffle of the mid-cap benchmark. The retailer and automotive services provider has
More